Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor
- 1 January 2014
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 461 (1-2) , 203-213
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mechanism of Interaction of Human Mitochondrial DNA Polymerase γ with the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine Indicates a Low Potential for Host ToxicityAntimicrobial Agents and Chemotherapy, 2012
- Acceptability of Vaginal Film, Soft-Gel Capsule, and Tablet as Potential Microbicide Delivery Methods Among African WomenJournal of Women's Health, 2011
- Effect of Molecular Weight and Concentration of Polyethylene Glycol on Physicochemical Properties and Stability of Shellac FilmJournal of Agricultural and Food Chemistry, 2010
- Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNAExpert Opinion on Drug Metabolism & Toxicology, 2010
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase InhibitorJournal of Biological Chemistry, 2009
- Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterizationInternational Journal of Pharmaceutics, 2009
- In Vitro and In VivoJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Microbicides: a new approach to preventing HIV and other sexually transmitted infectionsNature Reviews Drug Discovery, 2002
- Predicting Plasticization Efficiency from Three-Dimensional Molecular Structure of a Polymer PlasticizerPharmaceutical Research, 2001